On Friday 14’th January, the World Health Organization recommended the use of two new drugs Baricitinib and Casirivimab-Imdevimab for the […]
January 18, 2022The pharmaceutical industry is changing rapidly. Due to increasing chronic diseases and after the Covid-19 outbreak, there came a massive […]
October 25, 2021In the peak time of the Covid pandemic outbreak, countries like Brazil sought a shortage of essential medicines and medical […]
October 21, 2021Third-party pharma manufacturing facilitates a bridge between the manufacturer and the organization/ hospitals in need of a product with standard […]
October 20, 2021We, Ikris Pharma Network are International pharmaceutical distributors from India. We supply products to all the people involved in the […]
October 20, 2021Ikris Pharma Network was founded in 2014 and is based in Noida, India. We are one of the most reliable […]
August 18, 2021Due to the impact of COVID-19, the pharmaceutical sector sought contract manufacturing in a big way. Its growth from USD […]
July 28, 2021In FDA jargon, RLD stands for Reference Listed Drug. Let’s throw a couple of more familiar acronyms in the mix: […]
July 22, 2021The demand for generic medicines is increasing at the global level and pharmaceutical companies are realising the huge potential this […]
July 19, 2021According to findings from an exploratory analysis of the Phase-III MONALEESA-7 trial presented during the 2021 ESMO Breast Cancer Virtual […]
June 9, 2021Introduction: In recent times, biosimilars have unfolded as a transformative potential in the pharma and healthcare markets. These complex biological […]
On May 23, 2023, the US FDA approved Innoviva’s new antibiotic therapeutic medicinal product, Xacduro (sulbactam-durlobactam), to treat ventilator-associated bacterial […]
On August 24, 2023, the U.S. FDA approved Tyruko (natalizumab-sztn), the first biosimilar to drug Tysabri (natalizumab) injection for treating […]
In a significant development on August 11, 2023, the Food and Drug Administration (FDA) granted its approval for the combined […]
Ethics in clinical research, particularly in the context of human trials, holds paramount importance. The concept of ethics revolves around determining […]
Key Takeaways: The US FDA grants accelerated approval for medicine Elrexfio (elranatamab-bcmm) for Relapsed or Refractory (R/R) Multiple Myeloma. This […]
Key Takeaways: Variant EG.5, dubbed/nicknamed “ERIS,” is the fast-spreading new strain of COVID-19. World Health Organization (WHO) has declared the […]
In recent years, India’s pharmaceutical industry has cemented its position as a global leader in pharmaceutical product exports. The Gulf […]
The menace of fake and counterfeit medicines is a matter of concern for patients as counterfeit medications have serious health […]
In the field of clinical research and medication development, the successful sourcing of commercial pharmaceuticals for clinical trials is critical to ensuring […]
We love to partner with brands and products that we believe in. If you feel that your company shares values and would benefit our readers, we would love to talk about working together.
Learn More